BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34311118)

  • 1. Ultrasound-Guided Radiofrequency Ablation for the Treatment of Primary Hyperparathyroidism: An Efficacy and Safety Study.
    Li X; Tufano RP; Russell JO; Yan L; Xiao J; Li Y; Zhang M; Luo Y
    Endocr Pract; 2021 Dec; 27(12):1205-1211. PubMed ID: 34311118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
    Qiu X; Gao M; Zhang D; Ji F
    Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics.
    Ha EJ; Baek JH; Baek SM
    Korean J Radiol; 2020 Dec; 21(12):1383-1392. PubMed ID: 32767864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Primary Hyperparathyroidism: A Prospective Study.
    Chai HH; Zhao Y; Zeng Z; Ye RZ; Hu QH; He HF; Baek JH; Peng CZ
    Korean J Radiol; 2022 May; 23(5):555-565. PubMed ID: 35506529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation.
    Peng CZ; Chai HH; Zhang ZX; Hu QH; Zeng Z; Cui AL; Pang HS; Ruan LT
    Int J Hyperthermia; 2022; 39(1):490-496. PubMed ID: 35285391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience.
    Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Li D; Yue W; Peng C; Xu HX
    Endocrine; 2024 Mar; 83(3):681-690. PubMed ID: 37725290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia.
    Zeng Z; Peng CZ; Liu JB; Li YW; He HF; Hu QH; Lin B; Shen XG
    Sci Rep; 2020 Apr; 10(1):6206. PubMed ID: 32277134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-Guided Radiofrequency Ablation in Tertiary Hyperparathyroidism: A Prospective Study.
    Deng E; Jiang T; Chai H; Weng N; He H; Zhang Z; Peng C; Yue W; Xu H
    Korean J Radiol; 2024 Mar; 25(3):289-300. PubMed ID: 38413113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study.
    Liu F; Liu Y; Peng C; Yu M; Wu S; Qian L; Han Z; Yu J; Chai H; Liang P
    Eur Radiol; 2022 Nov; 32(11):7743-7754. PubMed ID: 35593958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study.
    Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Chai HH; Yu MA
    Int J Hyperthermia; 2021; 38(1):1023-1030. PubMed ID: 34219596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study.
    Chen CC; Chen HL; Chiang PL; Luo SD; Chang YH; Chen WC; Wang CK; Lin AN; Chen YS; Chi SY; Lin WC
    Int J Hyperthermia; 2022; 39(1):907-917. PubMed ID: 35848429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study.
    Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Yu MA
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2707-2717. PubMed ID: 33846740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism.
    Qin X; Wang B; Li B; Lin C; Liu X; Xie X
    Ren Fail; 2021 Dec; 43(1):445-451. PubMed ID: 33663332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
    Wei Y; Peng L; Li Y; Zhao ZL; Yu MA
    Korean J Radiol; 2020 May; 21(5):572-581. PubMed ID: 32323502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.
    Ni W; Yuan Y; Chu X; Chen G; Han X; Li J; Wu X; Wang J; Liu C; Xu S
    Front Endocrinol (Lausanne); 2021; 12():782050. PubMed ID: 34925241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US-Guided Percutaneous Microwave Ablation for Primary Hyperparathyroidism with Parathyroid Nodules: Feasibility and Safety Study.
    Liu C; Wu B; Huang P; Ding Q; Xiao L; Zhang M; Zhou J
    J Vasc Interv Radiol; 2016 Jun; 27(6):867-75. PubMed ID: 27106734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation.
    Yue W; Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Xu D; Peng C
    Int J Hyperthermia; 2023; 40(1):2223370. PubMed ID: 37344379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
    Xu W; Li S; Cheng F; Gong L; Tang W; Lu J; Li Y; Wang Z
    Int Urol Nephrol; 2023 Sep; 55(9):2237-2247. PubMed ID: 36892812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease.
    Peng C; Zhang Z; Liu J; Chen H; Tu X; Hu R; Ni J; Weng N; Pang H; Xue Z
    Head Neck; 2017 Mar; 39(3):564-571. PubMed ID: 28032671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of the radiofrequency ablation of single hyperfunctioning parathyroid lesions suggestive of adenomas in primary hyperparathyroidism.
    León Utrero S; Garrido-Pareja F; López-Ibarra P; Quesada-Charneco M; López-Mezquita E; Ávila-Rubio V; Martín-Rodríguez JL
    J Endocrinol Invest; 2023 Nov; 46(11):2269-2273. PubMed ID: 37032399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.